NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-765-2013-0-DE-09 Multifunctional RNA Nanoparticles and Methods of Use DE EP 14780963.6 Issued
NCI E-765-2013-0-GB-11 Multifunctional RNA Nanoparticles and Methods of Use GB EP 14780963.6 Issued
NCI E-765-2013-0-AU-04 Multifunctional RNA Nanoparticles and Methods of Use AU National Stage 2014321443 Issued
NCI E-765-2013-0-JP-06 Multifunctional RNA Nanoparticles and Methods of Use JP National Stage 2016-543964 Issued
NCI E-078-2012-0-GB-10 Anti-Mesothelin Chimeric Antigen Receptors GB EP 13717593.1 Issued
NCI E-078-2012-0-FR-09 Anti-Mesothelin Chimeric Antigen Receptors FR EP 13717593.1 Issued
NCI E-078-2012-0-DE-08 Anti-Mesothelin Chimeric Antigen Receptors DE EP 13717593.1 Issued
NIAID E-172-2007-2-US-04 Aegyptin And Uses Thereof US DIV 14/488,983 9441022 Issued PDF
NCI E-765-2013-0-PCT-02 Multifunctional RNA Nanoparticles and Methods of Use PCT PCT PCT/US2014/056007 Expired
NCI E-273-2002-0-US-05 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US DIV 14/489,127 Abandoned
NCI E-250-2014-0-US-01 Anti-CD276 Polypeptides and Proteins US 62/051,650 Abandoned
NINDS E-025-2013-0-US-03 METHOD OF ANALYZING MULTI-SEQUENCE MRI DATA FOR ANALYSING BRAIN ABNORMALITIES IN A SUBJECT US National Stage 14/385,509 9888876 Issued PDF
NINDS E-143-2002-1-US-42 Zenapax (Humanized Antibody Against The IL-2 Receptor Alpha Chain) As A Novel Treatment For Multiple Sclerosis US CON 14/487,012 Abandoned
NIAID E-050-1997-1-US-22 METHOD FOR DETECTING THE PRESENCE OF A TARGET NUCLEIC ACID SEQUENCE IN A SAMPLE US DIV 14/486,467 Abandoned
NCI E-019-2012-0-US-04 Soluble Engineered Monomeric FC US National Stage 14/385,133 9676857 Issued PDF
NCI E-135-2012-0-US-03 DNA Methylation For The Diagnosis, Prognosis And Treatmemt Of Adrenal Neoplasms US National Stage 14/384,583 9428813 Issued PDF
NHLBI E-114-2013-0-PCT-02 Balanced Two-arm X-Ray Grating Interferometer PCT PCT PCT/US2014/055225 Expired
NHLBI E-113-2013-0-PCT-02 Demodulation Of Intensity Modulation In X-Ray Imaging PCT PCT PCT/US2014/055224 Expired
NHLBI E-165-2014-0-US-01 Lentiviral Vector for Treating Hemoglobin Disorders US 62/048,881 Abandoned
NIA E-205-2006-2-AU-20 Preparation Of (R,R)-fenoterol And (R,R)- or (R,S)-fenoterol Analogues And Their Use in Treating Congestive Heart Failure AU DIV 2014224073 Abandoned
NCI E-054-2013-2-NZ-02 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES NZ National Stage 630790 Issued
NCI E-078-2012-0-US-06 Anti-Mesothelin Chimeric Antigen Receptors US National Stage 14/384,282 9359447 Issued PDF
NIDCR E-038-2013-1-US-02 SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH482524 US CON 14/482,524 Abandoned
NCI E-207-2004-3-US-04 Plasmids And Phages for Homologus Recombination And Methods of Use US DIV 14/481,795 9371532 Issued PDF
NIDDK E-224-2012-0-PCT-02 Bridged Bicyclic Thiazepinones and Methods of Their Use PCT PCT PCT/US2014/054660 Abandoned
NCATS E-287-2011-0-SG-15 Amido Compounds As RORgt Modulators And Uses Thereof SG National Stage 11201400456R Pending
NIA E-051-2008-0-AU-09 Compositions And Methods For Delivering Inhibitory Oligonucleotides AU DIV 2014221306 Abandoned
NIDDK E-234-2011-2-US-02 Conjugating Amines US National Stage 14/128,958 9616139 Issued PDF
NIDA E-286-2015-0-US-03 Induction Of Highly Specific Antibodies To A Hapten But Not To A Carrier Peptide By Immunization US National Stage 14/377,126 9193739 Issued PDF
NIMH E-175-2004-0-US-10 Scopolamine For The Treatment Of Depression And Anxiety US DIV 14/478,442 9707220 Issued PDF
NIDDK E-249-2014-0-US-01 LIN28 EXPRESSING LENTIVIRUS VECTORS WITH ERYTHROID PROMOTERS AND KNOCKDOWN OF LET-7 MICRO RNAS TO INCREASE FETAL HEMOGLOBIN PRODUCTION US 62/046,247 Abandoned
NICHD E-247-2009-2-US-08 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes US CON 14/477,725 10172951 Issued PDF
NIDDK E-539-2013-0-PCT-02 Thioether Prodrug Compositions As Anti-HIV And Anti-Retroviral Agents PCT PCT PCT/US2014/054019 Expired
NIAID E-178-2014-0-US-01 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US 62/046,059 Abandoned
NIAID E-076-2015-0-US-01 Methods and compositions for Inducing Protective Immunity Against Filovirus Infection US 62/045,522 Abandoned
NCATS E-072-2015-0-CA-06 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA CA National Stage 2922821 Issued
NCATS E-072-2015-0-EP-18 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA EP DIV 19150428.1 Issued
NCATS E-072-2015-0-JP-12 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA JP National Stage 2016-537941 Issued
NCATS E-072-2015-0-AU-04 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA AU National Stage 2014311977 Issued
NCATS E-072-2015-0-SA-14 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA SA National Stage 516370640 Issued
NCATS E-072-2015-0-EP-10 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA EP National Stage 14841207.5 Issued
NIAID E-219-2016-0-PCT-02 Serum Antibody Assay For Determining Protection From Malaria, And Pre-Erythrocytic Subunit Vaccines PCT PCT PCT/US2014/053745 Expired
NCATS E-072-2015-0-PCT-02 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA PCT PCT PCT/US14/053756 Expired
NCATS E-072-2015-0-MX-16 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA MX National Stage MX/A/2016/002632 Pending
NCATS E-072-2015-0-BR-05 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA BR National Stage BR112016004320-0 Pending
NCATS E-072-2015-0-AE-03 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA AE National Stage 215/2016 Pending
NCI E-132-2012-0-US-04 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions US National Stage 14/382,281 9415099 Issued PDF
NCI E-257-2014-0-US-01 Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis US 62/043,880 Abandoned
NINDS E-251-2005-0-US-13 SYSTEMS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA US CON 14/471,369 1007-10-16 Issued PDF
NEI E-113-2010-0-US-07 Nitisinone For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation US CON 14/471,142 9364448 Issued PDF